Companies / Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd
Financials · FY2025
Ownership
1.17B shares outstanding · as of Jun 30, 2026
Ownership
| Institutions | 61.51% | 716,812,260 |
| Public float | 38.49% | 448,483,824 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 14
View all →| Insider | % of shares | Shares |
|---|---|---|
Barer Sol JDirector | — | — |
Daniell RichardEVP, Europe Commercial | — | — |
Fox ChristineEVP, U.S. Commercial | — | — |
Francis Richard DCEOPresident and CEO | — | — |
Hughes Eric ASee "Remarks" | — | — |
Jover PlacidSee "Remarks" | — | — |
Kalif Eliyahu SharonEVP, Chief Financial Officer | — | — |
Lieberman Gerald MDirector | — | — |
Lippman EvanEVP, Business Development | — | — |
Mignone RobertoDirector | — | — |
Institutional holders 638
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.16B | 5.48% | |
| $1.28B | 3.53% | |
| $1.19B | 3.40% | |
| $1.16B | 3.50% | |
| $1.10B | 3.02% | |
| $905.56M | 2.49% | |
| $887.07M | 2.44% | |
| $666.51M | 1.83% | |
| $641.57M | 1.63% | |
| $334.64M | 0.98% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Francis Richard D CEO | Sell | Ordinary Shares | $13.33M | -412K -26.87% | 1,121,382 0.10% of shares | high |
| Feb 26, 2026 | Kalif Eliyahu Sharon Executive | Sell | Ordinary Shares | $11.63M | -346K -85.75% | 57,478 <0.01% of shares | high |
| Feb 15, 2026 | Francis Richard D CEO | Sell | Ordinary Shares | $9.79M | -286K -32.08% | 605,771 0.05% of shares | medium |
| Feb 15, 2026 | Francis Richard D CEO | Sell | Ordinary Shares | $5.53M | -162K -37.30% | 271,783 0.02% of shares | medium |
| Mar 3, 2026 | Hughes Eric A Executive | Sell | Ordinary Shares | $2.22M | -69K -44.51% | 85,616 <0.01% of shares | medium |
| Mar 3, 2026 | Daniell Richard Executive | Sell | Ordinary Shares | $2.16M | -67K -35.15% | 123,127 0.01% of shares | medium |
| Mar 3, 2026 | Daniell Richard Executive | Sell | Ordinary Shares | $2.01M | -62K -56.27% | 48,384 <0.01% of shares | medium |
| Mar 17, 2026 | Sabag Mark Executive | Sell | Ordinary Shares | $1.87M | -62K -21.64% | 224,940 0.02% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Migdal Insurance & Financial Holdings Ltd | Passive13G | — |
| Harel Insurance Investments & Financial Services Ltd. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| TEVA | ADR | 881624209 |